EP2872161
DIANHYDROGALACTITOL FOR USE IN TREATING TYROSINE-KINASE-INHIBITOR-RESISTANT MALIGNANCIES IN PATIENTS WITH GENETIC POLYMORPHISMS OR AHI1 DYSREGULATIONS OR MUTATIONS
Status:
EP einkaleyfi: Þýðing ekki lögð innEP appl. date:
24.6.2013EP published:
16.12.2020EP application number:
13809749.8
EPO information:
European Patent Register
Max expiry date:
23.6.2033
Title:
DIANHYDROGALACTITOL FOR USE IN TREATING TYROSINE-KINASE-INHIBITOR-RESISTANT MALIGNANCIES IN PATIENTS WITH GENETIC POLYMORPHISMS OR AHI1 DYSREGULATIONS OR MUTATIONS
Timeline
Today
24.6.2013EP application
16.12.2020EP Publication
Owner
Name:
Del Mar PharmaceuticalsAddress:
Suite 115-887 Great Northern Way, Vancouver, CA
Inventor
Name:
BROWN, Dennis M.Address:
Menlo Park, California 94025, US
Name:
BACHA, Jeffrey A.Address:
Vancouver, British Columbia V5T 4T5, CA
Name:
GARNER, William J.Address:
San Francisco, California 94109, US
Priority
Number:
201261664279 PDate:
26.6.2012Country:
US
Number:
201361824672 PDate:
17.5.2013Country:
US
Classification
Categories:
A61K 31/047, A61K 31/075, A61K 31/336, A61K 45/06, A61K 38/12, A61P 35/00, A61P 35/02